Therefore, we examined the combined effect of THBS1 inhibition and CRC chemotherapy, including folinic acid, fluorouracil, and oxaliplatin (FOLFOX) (Fig. 7k). This evidence concerns the gene THBS1 and colorectal carcinoma.